genOway

Biotechnology ResearchAuvergne-Rhône-Alpes, France51-200 Employees

genOway, founded in 1999 and based in Lyon, France, operates in biotechnology research with a focus on preclinical models. It develops genetically engineered models to bridge the gap between early findings and clinical applications, offering customized mice and rats as well as ready-to-use cell lines to improve predictability and speed up therapeutic research. The company collaborates with a global network of customers that includes many of the world’s leading pharmaceutical firms, biotech companies, contract research organizations, and academic institutions, supported by a diverse, multinational team. 

Its product and service portfolio combines a catalog of validated, ready-to-use models developed in partnership with biopharma leaders, with options for custom-made models and proof-of-concept experiments aligned to project goals. GenOway emphasizes scientific rigor, easy access to high-health-status models sourced from certified breeders in the US and Europe, and strong collaborations that enable model co-validation, along with a secure framework for technology use through guaranteed freedom to operate in the relevant field. As part of its sustainability efforts, the genOway Low-Carbon Project, started in 2021, targets gradual greenhouse gas reductions and has reported measurable progress toward its five-year goals.

Sign up for free to view info

Email Format Employee directory